GRIN: " GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: An assessor-masked randomised comparison trial": Study protocol
dc.contributor.author | Thomas, R. | |
dc.contributor.author | Johnston, L. | |
dc.contributor.author | Boyd, Roslyn | |
dc.contributor.author | Sakzewski, L. | |
dc.contributor.author | Kentish, M. | |
dc.date.accessioned | 2017-01-30T11:57:58Z | |
dc.date.available | 2017-01-30T11:57:58Z | |
dc.date.created | 2015-10-29T04:10:13Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Thomas, R. and Johnston, L. and Boyd, R. and Sakzewski, L. and Kentish, M. 2014. GRIN: " GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: An assessor-masked randomised comparison trial": Study protocol. BMC Pediatrics. 14 (1). | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/16826 | |
dc.identifier.doi | 10.1186/1471-2431-14-35 | |
dc.description.abstract |
Background: Cerebral palsy is the most common cause of physical disability in childhood. Spasticity is a significant contributor to the secondary impairments impacting functional performance and participation. The most common lower limb spasticity management is focal intramuscular injections of Botulinum Toxin-Type A accompanied by individually-delivered (one on one) physiotherapy rehabilitation. With increasing emphasis on improving goal-directed functional activity and participation within a family-centred framework, it is timely to explore whether physiotherapy provided in a group could achieve comparable outcomes, encouraging providers to offer flexible models of physiotherapy delivery. This study aims to compare individual to group-based physiotherapy following intramuscular Botulinum Toxin-A injections to the lower limbs for ambulant children with cerebral palsy aged four to fourteen years.Methods/Design: An assessor-masked, block randomised comparison trial will be conducted with random allocation to either group-based or individual physiotherapy. A sample size of 30 (15 in each study arm) will be recruited. Both groups will receive six hours of direct therapy following Botulinum Toxin-A injections in either an individual or group format with additional home programme activities (three exercises to be performed three times a week). Study groups will be compared at baseline (T1), then at 10 weeks (T2, efficacy) and 26 weeks (T3, retention) post Botulinum Toxin-A injections. Primary outcomes will be caregiver/s perception of and satisfaction with their child's occupational performance goals (Canadian Occupational Performance Measure) and quality of gait (Edinburgh Visual Gait Score) with a range of secondary outcomes across domains of the International Classification of Disability, Functioning and Health.Discussion: This paper outlines the study protocol including theoretical basis, study hypotheses and outcome measures for this assessor-masked, randomised comparison trial comparing group versus individual models of physiotherapy following intramuscular injections of Botulinum Toxin-A to the lower limbs for ambulant children with cerebral palsy.Trial registration: ACTRN12611000454976. © 2014 Thomas et al.; licensee BioMed Central Ltd. | |
dc.title | GRIN: " GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: An assessor-masked randomised comparison trial": Study protocol | |
dc.type | Journal Article | |
dcterms.source.volume | 14 | |
dcterms.source.number | 1 | |
dcterms.source.title | BMC Pediatrics | |
curtin.department | School of Occupational Therapy and Social Work | |
curtin.accessStatus | Open access via publisher |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |